Literature DB >> 32431409

Informed Consent and Advance Care Directives: Cornerstones and Outstanding Issues in the Newly Enacted Italian Legislation.

Gianluca Montanari Vergallo1, Antonio G Spagnolo2.   

Abstract

This article's authors delve into, and comment on, some of the key provisions within law no. 219, passed in 2017, which came into full effect in 2018. The legislation presents several innovative aspects: (a) communication time is equated to care; (b) patients may turn down lifesaving treatments, yet doctors must put in place all suitable support processes, from a psychological standpoint as well, in order to make sure that patients make informed decisions in full awareness; (c) refusal to treatment may be expressed prior to the onset of the disease making the patient incapable, as long as the advance directive is laid out by a mentally capable adult who has been provided with all relevant medical information available as to the consequence of a refusal to undergo a given treatment; (d) artificial nutrition and hydration are tantamount to treatment; thus, they may not be carried out and kept in place in absence of valid consent; (e) patients may appoint a healthcare proxy holder, tasked with interacting with doctors and caregivers and expressing consent or refusal; (f) patient will, whether current or advance, must be complied with even under emergency or urgency conditions, provided that clinical conditions and circumstances make it possible to acquire it; (g) doctors may disregard advance directives only when specifically provided for by the law; (h) patients may not demand treatment deemed to be illegal or running counter to ethical codes or scientific evidence. The new legislation, therefore, is meant to uphold the right to exercise self-determination as well as the patient's quality of life, yet ensuring that doctors remain fully capable of making the decisions that they are best positioned to. Summary: The Italian Parliament has for the first time regulated the issue of consent and refusal of healthcare treatments, whether currently expressed or advance. This article elaborates on recent Italian legislation that details a patient's right to consent to or refuse treatment in advance, including refusal of artificial nutrition and hydration, the duty of doctors in the event of an emergency, the shared planning treatment, the role of durable power of attorney, and advance healthcare directives. © Catholic Medical Association 2019.

Entities:  

Keywords:  Advance care planning; Advance healthcare directives; Current refusal; Healthcare treatment; Informed consent; Italian law; Palliative care

Year:  2019        PMID: 32431409      PMCID: PMC6699049          DOI: 10.1177/0024363919837863

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  8 in total

1.  Enough. The failure of the living will.

Authors:  Angela Fagerlin; Carl E Schneider
Journal:  Hastings Cent Rep       Date:  2004 Mar-Apr       Impact factor: 2.683

2.  Advance healthcare directives: moving towards a universally recognized right.

Authors:  G Montanari Vergallo; F P Busardò; P Berretta; E Marinelli; S Zaami
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-05       Impact factor: 3.507

3.  Comment on "The static evolution of the new Italian code of medical ethics".

Authors:  S Ricci; A Di Luca; N M Di Luca
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-07       Impact factor: 3.507

Review 4.  Law on advance health care directives: a medical perspective.

Authors:  A Di Luca; A Del Rio; M Bosco; N M Di Luca
Journal:  Clin Ter       Date:  2018 Mar-Apr

Review 5.  End-of-life, euthanasia, and assisted suicide: An update on the situation in France.

Authors:  R Aubry
Journal:  Rev Neurol (Paris)       Date:  2016-10-21       Impact factor: 2.607

6.  End-of-life decision-making and quality of ICU performance: an observational study in 84 Italian units.

Authors:  Guido Bertolini; Simona Boffelli; Paolo Malacarne; Mario Peta; Mariano Marchesi; Camillo Barbisan; Stefano Tomelleri; Simonetta Spada; Roberto Satolli; Bruno Gridelli; Ivo Lizzola; Davide Mazzon
Journal:  Intensive Care Med       Date:  2010-05-13       Impact factor: 17.440

7.  End-of-life decision-making in six European countries: descriptive study.

Authors:  Agnes van der Heide; Luc Deliens; Karin Faisst; Tore Nilstun; Michael Norup; Eugenio Paci; Gerrit van der Wal; Paul J van der Maas
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

8.  Limitation of the therapeutic effort: ethical and legal justification for withholding and/or withdrawing life sustaining treatments.

Authors:  Patrizia Borsellino
Journal:  Multidiscip Respir Med       Date:  2015-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.